ArticleWorld journal of urology2026
Global, regional, and national burden of urolithiasis, 1992-2021: analysis of data from the global burden of disease study 2021.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Prevention and treatment of urolithiasis: innovation and novel techniques.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeUrolithiasis is a common, recurrent condition that poses significant health and economic challenges. This study aims to assess the global, regional, and national trends in urolithiasis burden and explore its association with socio-demographic disparities from 1992 to 2021.
methodsWe utilized data from the Global Burden of Disease (GBD) 2021 to analyze the burden of urolithiasis across 204 countries and territories from 1992 to 2021. Age-standardized incidence rates (ASIR), DALY rates (AS-DALYR), and years of life lost rates (ASYR) were assessed. Inequality analysis was performed to evaluate socio-demographic disparities. Age-period-cohort (APC) analysis examined trends by age, period, and cohort.
resultsIn 2021, urolithiasis was responsible for 693,444 DALYs globally, with an AS-DALYR of 8.146 per 100,000 and 105,984,000 cases (ASIR: 1242.840). Despite a moderate global decline (AAPC: -0.159), males exhibited a higher burden, with 412,237 DALYs (AS-DALYR: 10.092) and an ASIR of 1685.100. Asia and Europe accounted for the highest burdens, while Oceania had the lowest. Regional disparities persisted, particularly in Europe and Oceania. APC analysis showed increasing age-specific risks in older populations, particularly in Americas and Europe. Limitations include data accuracy, bias of statistical models and limited consideration of risk factors.
conclusionThis study highlights persistent global inequalities in the urolithiasis burden, with marked regional and gender disparities. The burden remains particularly high in Asia and Europe, with increasing trends observed in Americas. Targeted interventions are urgently required, focusing on high-risk groups such as males, older adults, and specific birth cohorts.
trial registrationNot applicable.
Indexed as
Identifiers
41533143What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.